Breast cancer claims younger black female lives. If so, when should the screening begin?

Published Date: 26 Apr 2023

Once a woman turns 40, experts advise that she at the very least think about starting a breast cancer screening program. According to a recent study, Black women need this advice above all others.

Read Full News

Latest News

Planning Pregnancy in Crohn’s: Expert Insights

Dr Laura Sahyoun discusses the challenges of pregnancy in Crohn’s disease, with clinical guidance to help optimize care.

The Vascular Etiology of Migraine Myth

Neurologist Indu Subramanian asks migraine expert Andrew Charles how the vascular hypothesis emerged and what the imaging studies really show.

AI Saves Clinicians Time but Most Lack Training, Survey Finds

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Jun 05 2026 This Week in Cardiology

Managing Localized Uveal Melanoma: New Guideline Review

Dr Teresa Amaral reviews new guidelines for localized uveal melanoma, covering enucleation, radiotherapy nuances, and the current evidence on adjuvant systemic treatment.

Mavacamten Alters SCD Risk Scores, Not Outcomes

Data show marker improvement with mavacamten in obstructive HCM, but reclassification isn’t the same as proven mortality benefit — randomized or long-term outcome studies are still needed.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Latest News

Dr Laura Sahyoun discusses the challenges of pregnancy in Crohn’s disease, with clinical guidance to help optimize care.

Neurologist Indu Subramanian asks migraine expert Andrew Charles how the vascular hypothesis emerged and what the imaging studies really show.

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Dr Teresa Amaral reviews new guidelines for localized uveal melanoma, covering enucleation, radiotherapy nuances, and the current evidence on adjuvant systemic treatment.

Data show marker improvement with mavacamten in obstructive HCM, but reclassification isn’t the same as proven mortality benefit — randomized or long-term outcome studies are still needed.

News All Time

'Most Compelling' Data Yet for Metastasis-Directed Therapy in Prostate Cancer

But an association with improved overall survival failed to reach statistical significance

Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging

Will AI Replace Physicians? Can Prior Auth Be Fixed? A Q&A With HHS's Health IT Czar

Thomas Keane talks about artificial intelligence and other challenges facing his agency

First-of-Its-Kind Device for Pancreatic Cancer Wins FDA Approval

First approved therapy for locally advanced disease in almost three decades

Stereotactic Radiation Better for Patients With Multiple Brain Metastases?

Symptom severity, interference with daily functioning were improved

Should We Do a Shoulder MRI? Food Prescriptions for Diabetes

Also in TTHealthWatch: a planetary health diet, and patient views of statin therapy

Reining in Overdiagnosis of Papillary Thyroid Cancer: Easier Said Than Done

Cutting ultrasound referrals for nonpalpable nodules could lead to decreases in incidence

Beware of Radiation Doses Among Heart Scanners, Study Says

Coronary CT angiography, poorer countries under scrutiny for larger doses

Study Questions Use of Prostate Cancer Hormone Therapy in Certain Cases

Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients

Routine Mammograms That Also Flag CVD: Two Birds With One Stone?

AI-driven quantification of breast arterial calcification on imaging could ID higher-risk women

Tiny Blood Smidges in the Brain: Amount and Location Tied to Dementia

Neuroimaging findings believed to arise from distinct pathologies

Even Patients Are Shocked by the Prices Their Insurers Will Pay

And it costs all of us

Lead Suits Cut Physician Radiation Exposure for Interventional Cardiology Cases

Median exposure reduced to 0 versus lead apron during LAAO, with possible broader applicability

Ultrasound Treatment for Prostate Cancer Has Early Advantage Versus Prostatectomy

Better continence, erectile function, but data on oncologic outcomes still 2 years away

AI Strategy Could Eliminate Radiologist Review of Low-Risk Mammograms

Approach cut workload by 64% and increased cancer detection rate versus standard strategy

Deepfake X-Rays Sneak Past Radiologists and AI, Underscoring Abuse Potential

Unaware they were looking at phony images, a majority of radiologists judged fakes as real

Recommended News For You

Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.

For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.

Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

Mezigdomide Combinations Show Promise in Multiple Myeloma

ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death

Recommended Articles For You

The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure  

Improving TIVAP Use: Review of Standardization and Optimization Practices 

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care 

Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

2.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

3.

Capivasertib Wins Metastatic Prostate Cancer Approval

4.

A healthier lifestyle after bowel screening shown to prevent bowel cancer

5.

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

1.

Transformative Insights in Oncology in Daily Practice

2.

Thyroidectomy & Survival: Highlights from ASCO 2025 and Current U.S. Findings

3.

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment

4.

Predicting Incidental Prostate Cancer in BPH Surgery Patients

5.

Exploring the Potential of Cytologic Atypia in Cancer Diagnosis

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

3.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot